Skip to main content
ZYUS Life Sciences Corporation logo

ZYUS Life Sciences Corporation — Investor Relations & Filings

Ticker · ZYUS ISIN · CA9899601095 TSXV Professional, scientific and technical activities
Filings indexed 299 across all filing types
Latest filing 2025-05-29 Regulatory Filings
Country CA Canada
Listing TSXV ZYUS

About ZYUS Life Sciences Corporation

https://www.zyus.com/

ZYUS Life Sciences Corporation is a clinical-stage life sciences company dedicated to the development and commercialization of novel, non-opioid pharmaceutical drug candidates. The company focuses on proprietary cannabinoid-based therapeutics, or phyto-therapeutics, targeting the treatment of chronic and neuropathic pain. ZYUS's vision is to redefine the standard of care in pain management by developing evidence-based alternatives to conventional treatments, including opioids and NSAIDs. The core business involves advancing these drug product candidates through clinical trials, exemplified by the ongoing Phase 2a UTOPIA-1 trial evaluating a novel non-opioid pain drug.

Recent filings

Filing Released Lang Actions
Interim financial statements/report – English.pdf
Regulatory Filings
2025-05-29 English
Notice of meeting - English.pdf
Proxy Solicitation & Information Statement Classification · 90% confidence The document is a Notice of Annual General and Special Meeting of Shareholders detailing the meeting date, agenda items, proxy voting instructions, notice-and-access provisions, and references to the management information circular and related materials. It is not the AGM presentation itself (AGM-R), nor is it an actual financial report (10-K, IR), but a solicitation of proxies and information statement sent ahead of the shareholder meeting. Therefore, it fits the Proxy Solicitation & Information Statement category.
2025-05-27 English
Management information circular - English.pdf
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Notice of Annual General and Special Meeting of Shareholders accompanied by a Management Information Circular containing proxy details, resolutions to be voted on, director elections, auditor reappointment and governance information. These materials are sent to shareholders to solicit their votes at the meeting, matching the definition of a Proxy Solicitation & Information Statement (PSI).
2025-05-27 English
Form of proxy - English.pdf
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Form of Proxy for Zyus Life Sciences Corporation’s Annual General and Special Meeting, containing proxy voting guidelines, meeting logistics, resolutions to be voted on, and solicitation instructions. This falls under proxy solicitation materials, matching the “Proxy Solicitation & Information Statement” category.
2025-05-27 English
News release - English.pdf
Regulatory Filings Classification · 72% confidence The document is a Business Wire press release announcing initiation of clinical trial sites for a Phase 2A study of a new drug. It contains forward-looking statements and corporate commentary, not an earnings release, formal financial report, governance announcement, or any structured financial data. It does not match any specific SEC or corporate filing category and is a generic corporate press release. Under the fallback rule for miscellaneous regulatory or company announcements that don’t fit other categories, it should be classified as a Regulatory Filing (RNS).
2025-05-22 English
Material change report - English.pdf
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a “Notice of Annual and Special Meeting of Shareholders,” detailing the date, time, agenda items, proxy voting instructions, and record date. It is a solicitation for shareholder votes and refers to an accompanying Information Circular. This aligns with the definition for Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to provide information and request votes for meetings.
2025-05-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.